A Randomized, Multicenter, Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) Alone or in Combination with Lomustine in Recurrent WHO Grade IV Malignant Glioma Patients
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Istari Oncology
Start Date
November 6, 2018
End Date
July 23, 2024
Administered By
Duke Cancer Institute
Awarded By
Istari Oncology
Start Date
November 6, 2018
End Date
July 23, 2024